Synaptogenix, Inc. is a company that provides Fragile X syndrome, Medicine, G protein-coupled receptor and more. Synaptogenix, Inc. is headquartered in United States New York. Synaptogenix, Inc. was founded in 2012. Synaptogenix, Inc. has a total of 35 patents and 1 literature
Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1 and its analogs to discover and develop targeted therapeutics for neurodegenerative...